The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Open Orphan Unit To Assist SFA Therapeutics In Filing Drug Application

Wed, 18th Dec 2019 12:29

(Alliance News) - Open Orphan PLC on Wednesday said it has signed a contract with US-based biopharmaceutical firm SFA Therapeutics.

Open Orphan said it is "delighted" to support SFA Therapeutics in the development of its novel treatment. The drug consulting services platform said its subsidiary Venn Life Sciences will provide SFA Therapeutics with assistance in the filing of a European Medicines Agency application.

Open Orphan said this is an important contract as it is the first time that Venn has utilised Open Orphan's expertise in filing a European Medicines Agency application for a North American company, which already has a US Food & Drug Administration Orphan drug designation.

"This contract is a further demonstration of delivery against one of Open Orphan's key objectives, transforming Venn," said Open Orphan Chief Executive Cathal Friel.

"The contract is an exciting one as we are now building on our capability by actively winning work in the fast-growing orphan drug sector," added Friel.

Open Orphan shares were trading 2.7% higher in London on Wednesday morning at 5.80 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
9 Mar 2021 14:31

IN BRIEF: Open Orphan wins new contract with Oxford BioTherapeutics

IN BRIEF: Open Orphan wins new contract with Oxford BioTherapeutics

Read more
9 Mar 2021 11:38

Open Orphan subsidiary awarded contract with Oxford BioTherapeutics

(Sharecast News) - Specialist pharmaceuticals contract research organisation Open Orphan announced on Tuesday that its subsidiary Venn Life Sciences had been awarded a contract for a study with clinical-stage oncology company Oxford BioTherapeutics.

Read more
17 Feb 2021 13:48

IN BRIEF: Open Orphan Covid Characterisation Study Gets Approval

IN BRIEF: Open Orphan Covid Characterisation Study Gets Approval

Read more
3 Feb 2021 16:28

Open Orphan opens new quarantine clinic in Whitechapel

(Sharecast News) - Pharmaceutical services contract research organisation (CRO) Open Orphan has opened a new quarantine clinic in east London, it announced on Wednesday.

Read more
3 Feb 2021 11:55

IN BRIEF: Open Orphan Launches New Quarantine Clinic In London

IN BRIEF: Open Orphan Launches New Quarantine Clinic In London

Read more
1 Feb 2021 13:20

Open Orphan renews contract with Carna Biosciences

(Sharecast News) - Pharmaceutical services clinical research organisation Open Orphan announced a further contract renewal with Carna Biosciences on Monday, extending its integrated drug development consultancy services with Open Orphan subsidiary Venn Life Sciences.

Read more
1 Feb 2021 11:54

IN BRIEF: Open Orphan Inks Contract Renewal With Carna Biosciences

IN BRIEF: Open Orphan Inks Contract Renewal With Carna Biosciences

Read more
20 Jan 2021 21:16

IN BRIEF: Open Orphan Opens Two New Volunteer Recruitment Centres

IN BRIEF: Open Orphan Opens Two New Volunteer Recruitment Centres

Read more
11 Jan 2021 15:56

Open Orphan confirms first volunteer dosing of needle-free Covid vaccine

(Sharecast News) - Specialist pharmaceutical services contract research organisation Open Orphan announced on Monday that the first volunteer had been dosed with the Codagenix needle-free intranasal Covid-19 vaccine, 'COVI-VAC'.

Read more
11 Jan 2021 11:45

Open Orphan Doses First Volunteer In Needle Free Covid Vaccine Trial

Open Orphan Doses First Volunteer In Needle Free Covid Vaccine Trial

Read more
6 Jan 2021 14:37

IN BRIEF: Open Orphan Inks Contract Renewal With Top-3 Pharma Client

IN BRIEF: Open Orphan Inks Contract Renewal With Top-3 Pharma Client

Read more
23 Dec 2020 19:50

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

Read more
22 Dec 2020 14:26

IN BRIEF: Open Orphan Pens Contract Extension With Major Client

IN BRIEF: Open Orphan Pens Contract Extension With Major Client

Read more
22 Dec 2020 10:44

Open Orphan renews contract with top-3 pharma client

(Sharecast News) - Pharmaceutical services contract research organisation Open Orphan announced a contract renewal on Tuesday, extending its consultancy services with an unnamed "major top-three global" pharmaceutical client to December 2021.

Read more
14 Dec 2020 22:04

UK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid

UK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.